Despite the lack of further mTOR activation following chronic insulin stimulus, our findings indicate that both MCF-7 and MDA-MB-231 breast cancer cell lines exhibit a constitutively active mTOR pathway at baseline, a feature that is documented by other works [45,46]. The gene discussed is MTOR; the disease is breast carcinoma.